Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.338 USD | +0.35% | -3.74% | -0.51% |
09/05 | Lixte Biotechnology Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
23/04 | Lixte Biotechnology Files Up to $50 Million Mixed Shelf | MT |
End-of-day quotes
Sector Other Biotechnology & Medical Research
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
52.59L | - | - | - | - | - | |
5.46TCr | - | |||||
3.99TCr | ||||||
2.69TCr | ||||||
2.62TCr | ||||||
1.88TCr | - |